Phosphorylation of EGFR measured with in situ proximity ligation assay: Relationship to EGFR protein level and gene dosage in cervical cancer

Radiotherapy and Oncology

Volumn 101, Issue 1, 2011, Pages 152-157

  Halle, Cathinka ^a   Lando, Malin ^a   Sundfør, Kolbein ^b   Kristensen, Gunnar B ^b   Holm, Ruth ^b   Lyng, Heidi ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cervical cancer; EGFR; Gene dosage; Immunohistochemistry; Phosphorylation; Proximity ligation assay

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE DOSAGE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU PROXIMITY LIGATION ASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; COHORT STUDIES; CYTOPLASM; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; MIDDLE AGED; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; STATISTICS, NONPARAMETRIC; TYROSINE-TRNA LIGASE; UTERINE CERVICAL NEOPLASMS;

EID: 80051685792     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.05.052     Document Type: Article

References (29)

1. N. Normanno, L.A. De, and C. Bianco Epidermal growth factor receptor (EGFR) signaling in cancer Gene 366 2006 2 16 (Pubitemid 43199589)
2. R.E. Meyn, A. Munshi, J.V. Haymach, L. Milas, and K.K. Ang Receptor signaling as a regulatory mechanism of DNA repair Radiother Oncol 92 2009 316 322
3. S. Temam, H. Kawaguchi, and A.K. El-Naggar Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer J Clin Oncol 25 2007 2164 2170 (Pubitemid 46954638)
4. C.H. Chung, K. Ely, and L. McGavran Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas J Clin Oncol 24 2006 4170 4176 (Pubitemid 46622295)
5. T. Schlomm, P. Kirstein, and L. Iwers Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer Clin Cancer Res 13 2007 6579 6584 (Pubitemid 350206791)
6. D.S. Salomon, R. Brandt, F. Ciardiello, and N. Normanno Epidermal growth factor-related peptides and their receptors in human malignancies Crit Rev Oncol Hematol 19 1995 183 232
7. J. Giralt, H.M. de las, and L. Cerezo The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis Radiother Oncol 74 2005 101 108 (Pubitemid 40331866)
8. L. Bastholt, L. Specht, and K. Jensen Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck Radiother Oncol 85 2007 24 28 (Pubitemid 47562580)
9. M. Baumann, and M. Krause Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results Radiother Oncol 72 2004 257 266 (Pubitemid 39265378)
10. Y. Nieto, F. Nawaz, R.B. Jones, E.J. Shpall, and S. Nawaz Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer J Clin Oncol 25 2007 4405 4413 (Pubitemid 350013846)
11. R.L. Rego, N.R. Foster, and T.C. Smyrk Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status Br J Cancer 102 2010 165 172
12. Z. Weihua, R. Tsan, and W.C. Huang Survival of cancer cells is maintained by EGFR independent of its kinase activity Cancer Cell 13 2008 385 393 (Pubitemid 351609444)
13. Z. Li, Z. Chang, and L.J. Chiao TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation Cancer Res 69 2009 7851 7859
14. D.S. Gembitsky, K. Lawlor, A. Jacovina, M. Yaneva, and P. Tempst A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation Mol Cell Proteomics 3 2004 1102 1118 (Pubitemid 40012103)
15. T. Sun, M. Campbell, W. Gordon, and R.B. Arlinghaus Preparation and application of antibodies to phosphoamino acid sequences Biopolymers 60 2001 61 75 (Pubitemid 32601763)
16. O. Söderberg, M. Gullberg, and M. Jarvius Direct observation of individual endogenous protein complexes in situ by proximity ligation Nat Methods 3 2006 995 1000 (Pubitemid 44782698)
17. M. Jarvius, J. Paulsson, and I. Weibrecht In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method Mol Cell Proteomics 6 2007 1500 1509 (Pubitemid 47506163)
18. A. Zieba, C. Wahlby, and F. Hjelm Bright-field microscopy visualization of proteins and protein complexes by in situ proximity ligation with peroxidase detection Clin Chem 56 2010 99 110
19. H. Lyng, R.S. Brovig, and D.H. Svendsrud Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer BMC Genomics 7 2006 268
20. H. Lyng, M. Lando, and R.S. Brovig GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data Genome Biol 9 2008 R86
21. P. Hupe, N. Stransky, J.P. Thiery, F. Radvanyi, and E. Barillot Analysis of array CGH data: from signal ratio to gain and loss of DNA regions Bioinformatics 20 2004 3413 3422 (Pubitemid 40136776)
22. M. Aubele, M. Spears, and N. Ludyga In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues Br J Cancer 103 2010 663 667
23. K.H. Hsu, H.W. Tsai, P.W. Lin, Y.S. Hsu, Y.S. Shan, and P.J. Lu Osteopontin expression is an independent adverse prognostic factor in resectable gastrointestinal stromal tumor and its interaction with CD44 promotes tumor proliferation Ann Surg Oncol 17 2010 3043 3052
24. T. Hama, Y. Yuza, and Y. Saito Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma Oncologist 14 2009 900 908
25. Y. Wang, S. Pennock, X. Chen, and Z. Wang Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival Mol Cell Biol 22 2002 7279 7290
26. K. Roepstorff, L. Grovdal, M. Grandal, M. Lerdrup, and D.B. van Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer Histochem Cell Biol 129 2008 563 578
27. M. Hoshino, H. Fukui, and Y. Ono Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma Pathobiology 74 2007 15 21 (Pubitemid 46742314)
28. X. Wang, and A. Schneider HIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia Carcinogenesis 31 2010 1202 1210
29. J. Theys, B. Jutten, and L. Dubois The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironment Radiother Oncol 92 2009 399 404